We have investigated the cell surface recognition mechanisms used by human monocyte-derived macrophages (MO ) in phagocytosis of intact aging human neutrophils (PMNs) undergoing apoptosis. This study shows that the adhesive protein thrombospondin (TSP) was present in the interaction, both associated with the MO surface and in solution at a mean concentration of 0.59 ,g/ml. The interaction was inhibited by treatment of MO (but not aged PMN) with cycloheximide, but could be "rescued" by replenishment with exogenous TSP. Under control conditions, MO recognition of aged PMNs was specifically potentiated by purified platelet TSP at 5 ,g/ml, present either in the interaction or if preincubated with either cell type, suggesting that TSP might act as a "molecular bridge" between the two cell types. In support, both aged PMN and MO were found to adhere to TSP, and phagocytosis of aged PMN was specifically inhibited by (a) excess soluble TSP; (b) antibodies to TSP that also inhibit TSP-mediated adhesion to aged PMN; and (c) down-regulation of M4 receptors for TSP by plating MO on TSP-coated surfaces. Furthermore, inhibition with mAbs / Arg-Gly-Asp-Ser peptide of the candidate MO receptors for TSP, CD36, and a,83 exerted synergistic effects on both MO recognition of aged PMN and MO adhesion to TSP, indicating that "two point" adhesion of TSP to these MO structures is involved in phagocytosis of aged PMN. Our findings indicate newly defined roles for TSP and CD36 in phagocytic clearance of senescent neutrophils, which may limit inflammatory tissue injury and promote resolution. (J. Clin. Invest. 1992.90:1513-1522 many years ago (4), and, for example, has been shown to be the capable of binding to a wide range of macromolecules and many cell types (18) (19) (20) (21) (22) . TSP has been implicated as a "molec-1. Abbreviations used in this paper: EIgG, ox red erythrocytes opsonized with rabbit IgG; Fn, fibronectin; MO, monocyte-derived macrophages; RGDS, tetrapeptide Arg-Gly-Asp-Ser; RGES, control peptide Arg-Gly-Glu-Ser; TSP, thrombospondin; Vn, vitronectin; VnR, av,3 vitronectin receptor.
Introduction
In inflammation, neutrophils and their contents can injure tissue and may generate chemotactic factors with potential to amplify leukocyte infiltration ( 1, 2, 3) . Safe removal ofneutrophils from the perturbed site is, therefore, a prerequisite ofresolution ofinflammation. Uptake of intact senescent neutrophils by macrophages at resolving inflamed sites was recognized dominant mechanism of neutrophil clearance from the experimentally inflamed peritoneum (5, 6) . However, only recently have the mechanisms involved in this cellular interaction come under study. Building on earlier work (7) , we showed that human neutrophils isolated from blood or inflamed sites and aged for -24 h in culture undergo morphological and biochemical changes typical of programmed cell death (apoptosis), a process characterized by evidence of endogenous endonuclease activation ( 8-1 1 ). Apoptosis in aging neutrophils de- termined recognition and uptake ofthe intact senescent cell by human monocyte-derived macrophages and human macrophages isolated from inflamed sites in vivo. As apoptotic neutrophils retained their membrane integrity and did not release toxic contents, these processes appear to represent a mechanism for disposal of intact senescent neutrophils in a manner likely to limit their toxic potential (8) . In the present study, we examine the cell surface mechanisms used by macrophages in recognition of apoptotic neutrophils.
Previously, we found that the macrophage aCf33 integrin, or vitronectin receptor (VnR),' has a role in recognition of aged neutrophils (12) . The interaction depended on the divalent cations Ca"+ and Mg", and was specifically inhibited by (a) the tetrapeptide Arg-Gly-Asp-Ser (RGDS) at 1 mM, but not the control peptide Arg-Gly-Glu-Ser (RGES); (b) by soluble and substrate-bound fibronectin (Fn) and vitronectin (Vn), but not fibrinogen or type IV collagen, which also bear the RGD recognition sequence; and (c) by monoclonal antibodies to both subunits of the aCf33 integrin, which is expressed by the MO not the apoptotic neutrophil (12) (13) (14) . It was concluded that the VnR played a direct role in the recognition mechanism, a new function for this receptor in addition to its known roles in cell anchorage to matrix proteins ( 13 ) . However, MO recognition of aged neutrophils was also directly modulated by pH and specifically inhibited by millimolar concentrations of aminosugars and basic aminoacids in a charge-dependent fashion (15) , and such observations were not explained by the molecular interactions of the MO VnR.
Cationic amino sugars and basic amino acids also inhibit the trypsin-sensitive "lectin-like" property displayed by activated platelets in agglutination of fixed platelets and fixed trypsinized erythrocytes ( 16) . Subsequently, the activated platelet "lectin" was shown to be thrombospondin (TSP) ( 17) . TSP is a "multifunctional" trimeric adhesive molecule of -450 kD ular bridge" mediating adhesive interactions between activated platelets and other cells, including erythrocytes and monocyte/ macrophages (23) (24) (25) . However, the mechanisms by which TSP binds to cells are incompletely understood and potentially complex, since there is evidence that a number of cell surface molecules may be involved, including sulfatides, proteoglycans and proteins, including al33 and the 88-kD monomer GPIV/ CD36 (23, (25) (26) (27) (28) . Although first isolated from the a-granule of the platelet, TSP has been found to be synthesized and secreted by a wide range of cell types in culture (20) (21) (22) , including both macrophages and neutrophils (29, 30) , and there is evidence that each cell type may bear receptors for TSP (28, (31) (32) (33) (34) . Indeed, macrophages may have TSP associated with their surfaces (33, 34) . Furthermore, TSP has been shown to be a transient component of the inflammatory extracellular matrix of healing wounds present at the time in which neutrophils are removed from the tissue (35) , and has also been demonstrated in lavage fluid from inflamed lungs (36) . Consequently, in the present study, we sought evidence that TSP and TSP-binding structures were involved in MO recognition of aged neutrophils. Our data indicate that thrombospondin can act as a "molecular bridge" between the aged neutrophil and the MO, where the molecule appears to bind to both GPIV/ CD36 and the aCl33 integrin, indicating hitherto unrecognized functions for both TSP and GPIV/CD36.
Methods

Materials
All chemicals were from Sigma Chemical Co. (St. Louis, MO), unless otherwise indicated; culture media (HBSS, Iscove's DME) and supplements ( 100 U/liter of penicillin and streptomycin) were from Gibco Laboratories (Grand Island, NY); and sterile tissue culture plasticware were from Falcon Plastics (Cockeysville, MD).
Peptides and proteins
The tetrapeptides RGDS and RGES were obtained from Peninsula Laboratories, Inc., (Belmont, CA), human albumin (fraction V) was from Sigma and fibronectin from Calbiochem Corp. (San Diego, CA). TSP was purified from thrombin-stimulated human platelets by heparin-Sepharose affinity chromatography followed by "sizing" on a 4B-Sepharose column by standard methods (18) . Particular care was taken to use only those fractions in which the protein ran as a single band on reducing SDS-PAGE assessed by silver staining and immunoblotting with a mAb specific for TSP (TSP-B7; Sigma). Contamination with Vn was quantified at < 0.1% by specific ELISA (data courtesy of Dr. W. Bennett). Proteins and peptides were dialyzed in HBSS before use. (44) an IgM that recognizes the GPII-bIIIa complex, 28 (40, 44) an IgM recognizing CDI 5, and OX7 (Serotec, Banbury, Oxon, U.K.), an IgG, that recognizes Thyl. 1 . Antibodies were used as purified immunoglobulin (23C6, 11.2,P3) or ascites (C6.7, A2.5, A6. 1, D4.6, SMU, ClMegl, 23C6, P112, OX7) diluted in HBSS as described.
Monoclonal antibodies
Cells
Neutrophils (> 98% pure May-Giemsa) were isolated from fresh, citrated normal human blood by dextran sedimentation and plasma-Percoll (Pharmacia Fine Chemicals, Piscataway, NJ), aged in tissue culture for -28 h in Iscove's DME with 10% autologous platelet-rich, plasma-derived serum, and apoptosis verified by oil-immersion light microscopy of May-Giemsa stained cytopreps, exactly as previously described (8, 15) . Human monocyte-derived macrophages (M+) were prepared by standard methods from adherent PBMC by culture for 5-7 d in 24-well plates in Iscove's medium with 10% autologous serum as described (45, 8) . No contaminating platelets attached to M4 could be detected either by careful microscopic inspection or by immunofluorescence using mAb P112 specific for platelet GPIIbIIIa. For demonstration ofcell surface TSP by flow cytometry (see below), monocytes were purified by elutriation (46) and matured in nonadherent culture in teflon-lined vessels for 5-7 d. Ox erythrocytes, opsonized with polyclonal rabbit anti-ox IgG (gift from Dr. D. Grennan) were prepared as described ( 15) .
Assay and localization of TSP
TSP in solution in medium was assayed by ELISA exactly as described (34) , using rabbit polyclonal immunoglobulin specific for TSP ( 1:5,000 in PBS; a gift from Dr. N. Hunter); this assay was sensitive to a lower limit of 50 ng/ml. TSP was sought on the surface of cultured MO and neutrophils by immunofluorescence flow cytometry, using a standard protocol of labeling and three washes at the end of each step, as described ( 12) . Binding of C6.7 ( 1:100 dilution in PBS/0.1% BSA) was compared with an identical dilution of OX7 ascites as a control, detected using FITC-conjugated Fab'2 sheep anti-mouse immunoglobulin antibody ( 1:30; Sigma). Aged neutrophils were studied by the same techniques.
Interaction assays
This microscopically quantified phagocytic assay has been described and illustrated in detail before (8, 15) . Briefly, aged neutrophils were washed once in HBSS and suspended in HBSS. 2.5 X 106 aged PMN in 300 M1 HBSS were added to each washed well of MO and incubated at 37°C in a 5% CO2 incubator at pH 7.4. In view ofour previous findings of the importance ofpH ( 15) , particular care was taken to ensure that the pH of HBSS was adjusted and maintained correctly. At the end of the interaction period, the wells were washed in saline at 4°C, fixed with 2% glutaraldehyde in PBS, stained for myeloperoxidase and then the proportion of MO ingesting neutrophils counted by inverted light microscopy, exactly as described (8, 15) . In keeping with our previous description ofthis assay, the proportion ofM4 recognizing aged neutrophils varied between donors, so to compare data between experiments in which MO from different donors were used, data are presented as percentage ofthe mean of control in each ofthe relevant experiments, as described ( 15) . However, the absolute percentage ofM4 recognizing aged neutrophils in the relevant series of experiments is also given in the figure legend. Uptake of opsonized ox erythrocytes (EIgG) was determined by similar means, as described ( 15) . In all experiments, > 95% of Mk took up EIgG.
Effects ofproteins in solution. TSP or human albumin were included in the interaction medium at the desired concentration in HBSS and interactions performed in HBSS alone served as control. In preincubation experiments, proteins at S ug/ml were incubated with washed aged neutrophils or M4 at 37°C for 15 min (HBSS alone being used in "control" experiments), washed and then incubated with untreated MO or neutrophils as appropriate under the standard conditions ofthe assay.
Effects ofmonoclonal antibodies. These were determined as previously described (12, 15) . Briefly, adherent MO cultured in 24-well plates were washed, 300 Ml of mAb at desired concentration in HBSS (or HBSS alone as a control) was added to each well. The plates were incubated for 15 min at 4°C, followed by addition of 2.5 x 106 washed aged neutrophils (or EIgG) in 100 Al ofwarm HBSS and then interac-tion for 30 min under standard conditions. In no experiment did mAbs affect cell viability as assessed by trypan blue exclusion. In one series of experiments designed to determine the cellular localization ofthe effect ofmAb SMO either aged neutrophils (at 2.5 X 106/ml) or adherent MO were preincubated with mAb SM40 ( 1:25 dilution) for 30 min at 4VC, before washing twice in HBSS and interaction with untreated cells of the opposite type under standard conditions. These effects were compared with those of presence of mAb at the same concentration in the interaction medium, without the usual 15-min M4$ preincubation.
It should be noted that in previous work, a large number of murine mAbs of varying isotype have been examined in this assay in the form of intact Ig (either purified or as hybridoma ascites) ( 12, 15) . Except for mAbs to afl3, none has inhibited, including mAbs to MO and neutrophil surface structures, indicating that nonspecific "steric" effects are unlikely to be the reason for the blocking effects ofmAb in this system. Furthermore, no mAb (including those used in this study) have promoted M40 phagocytosis of freshly isolated neutrophils in a manner suggesting that murine mAbs might opsonize neutrophils for M4, thus complicating the interpretation of these data.
Effects ofplating M4 on tissue culture surfaces treated with proteins. TSP was adsorbed to the bottom oftissue culture-treated wells by standard methods (47) (48) (49) 27) . 50 Al of a solution of TSP or human albumin at 80 tg/ml in HBSS was incubated in each well of a 96-well flat-bottomed Falcon tissue culture plate for 2 h at room temperature and washed twice in HBSS and "control" wells were incubated with HBSS alone. Mature M4 were "mobilized" from adherent culture by methods shown by immunofluorescence flow cytometry to "strip" them of surface-associated TSP (data not shown) to facilitate modulation ofreceptors by substrate-bound proteins. Thus MO were incubated with 5 mM EDTA in HBSS with no Ca"+ or Mg"+ for 15 min at 4VC, detached from the plate by pipetting, washed twice in warm HBSS, suspended at 5 X 105/ml and 50 ,l of suspension added to each well. The cells, which formed a "subconfluent" monolayer, underwent receptor modulation (or not) during incubation at 370C for 30 min. The medium was then aspirated and replaced with 100 Ml ofa suspension of aged neutrophils in HBSS at 2.5 x 106/ml, or EIgG at 5 x 106/ml for a 30-min interaction. Counting of M40 by inverted microscopy showed that < 10% of Mk originally added to the well were lost during these steps, indicating that adherent MO were not a subpopulation.
Assay ofadhesion ofaged neutrophils to latex beads
In preliminary experiments, apoptotic PMN did not spread on tissue culture-treated surfaces or hemocytometer glass, remaining spherical and resisting mechanical displacement only weakly (Whyte, M.K.B., J.S. Savill, and C. Haslett; unpublished data). Consequently, we sought adhesion to protein-coated 0.995-,Mm latex beads (LBl 1; Sigma) by minor modifications of standard methods (50, 51 ) , since this does not require neutrophil spreading. A 300-Ml aliquot of a 10% stock suspension of latex beads was added to a 1.5-ml polythene Eppendorf tube, pelleted and washed three times in 0.9% saline, and then incubated with either TSP or human Fn (Calbiochem) at 100 gg/ml in 0.9% saline with Tris HCl 20 mM, pH 7.4, for 10 min at room temperature. The bead suspension was then sonicated with a probe sonicator (60 W) to break up microclumps, centrifuged and resuspended in 10 mg/ml human albumin in HBSS, then incubated for a further 10 min at room temperature. Beads were pelleted and washed three times in HBSS before resuspension in 500 Ml HBSS; i.e., a 6% suspension. TSP coating was confirmed by positive indirect immunofluorescence with mAb 11.2 at 2.5 Ag/ml and negative staining with irrelevant mAb P3 at the same concentration. Aged neutrophils were washed and resuspended at 50 X 106/ml in HBSS, and 225 ,l were added to each test tube (Falcon LP3 polythene tubes). In some experiments TSP mAbs C6.7, A2.5, A6. 1, and D4.6 were included in the medium at a dilution of 1 in 25 of ascites. 25 ml offreshly prepared 6% beads was added to the cell suspension to achieve a final bead concentration of 0.6%, and the tube was shaken in a 370C water bath at 110 beats/min for 15 min, supplemented by manual agitation at 7 min. In preliminary experiments under these conditions, TSP mAbs at the concentration described above did not aggregate either beads or aged neutrophils alone, indicating that inhibitory effects on bead binding were unlikely to be by such "artefactual" mechanisms that might have reduced the area of interface between beads and cells. The cells were fixed by addition of 250 M1 of 2% glutaraldehyde in PBS for 10 min, and then cells separated from unbound beads (which are oflower density) by four consecutive centrifugations at 200 g for 4 min with washing in 0.9% saline, before finally suspending beads in 250 Ml 0.9% saline and placing 50 M1 on a microscope slide. The cells were inspected by oil immersion light microscopy after placing a cover slip on the drop. 500 neutrophils were examined to determine the percentage of cells binding beads, and then the number of beads on each of 100 cells with beads were counted.
Assay ofMq adhesion
Established methods (47, 27) , with minor modifications, were used. Tissue culture wells in 96-well flat bottomed Falcon plates were incubated with gelatin (Sigma) at 30 mg/ml in water for 2 h at 370C, aspirated to dryness and then thoroughly dried in an oven at 40C for a further 2 h. The wells were then cooled, and 50 Ml ofTSP or Fn (Calbiochem) at 40 Mg/ml incubated in each well for 2 h at room temperature.
HBSS alone was used as a control. The protein suspension was then aspirated, the wells washed twice with HBSS, and the remaining medium was aspirated. Mature (5 to 7 d) MO were released from adherent tissue culture by incubation with 5 mM EDTA in the cold, washed as above, and suspended at 106/ml in HBSS alone or HBSS with inhibitors/controls. The following inhibitors or controls were dissolved in HBSS and used at the stated concentration, either alone or in combination: RGDS and RGES at 2.2 mM; the CD36 mAb SMO, the a!f33 mAb 23C6, and the control mAbs P112 and OX7 were all in the form of ascitic fluid diluted 1:25. From these cell suspensions, 50-,Ml aliquots were immediately added to protein-coated wells for 45 min at room temperature followed by washing with 0.9% saline at 4°C. The wells were fixed with 2% glutaraldehyde in PBS, and the number ofadherent M4 in 10 randomly selected microscope fields counted using an inverted instrument with a 40X objective.
Treatment ofPMNs and Mk with cycloheximide
PMNs isolated from the same donor were cultured either under standard conditions (see above), or in conditions that were identical, except for the presence of cycloheximide at 5 x 10-6 M. Before interaction with MO under standard conditions, PMNs were washed three times to ensure removal of cycloheximide, and viability was determined by trypan blue exclusion. Adherent MO in 24-well plates were washed twice in HBSS, then incubated for 6 h in 5% CO2 at 37°C in Iscove's DME as a control, or with the same medium containing cycloheximide at 2.5 X 10-6 M. At the end ofthis period, aliquots ofmedium were taken for measurement of TSP concentration by ELISA (see above). The wells were then washed three times and interacted with aged neutrophils or EIgG under standard conditions. In some experiments, the interaction medium contained TSP, Fn, or human albumin at 4 Mg/ml.
Results
Macrophage-synthesized TSP participates in phagocytosis of apoptotic neutrophils. We first investigated whether TSP was present in the standard interaction assay in which 106 MO were coincubated with 2.5 X 106 aged PMN in 300 ,l of serum-free medium for 30 min. In keeping with previous studies (29, 33, 34) , TSP could be demonstrated in two forms. First, TSP was detected in medium at the end of the interaction at a concentration of 0.59±0.14 ,g/ml (n = 6); second, low levels of TSP were detected on the surface of MO by immunofluorescence flow cytometry (Fig. 1 ). However, TSP could not be demonstrated by the same techniques on the surface of aged PMN (data not shown). Furthermore, we confirmed that the capac- ity of MO to synthesize TSP was comparable to that previously reported (29) , and was over 40-fold greater than that of aged PMN (Table I) . Finally, to determine ifTSP might play a role in Mi recognition ofaged PMN, we studied whether the interaction was influenced by manipulation of MO TSP synthesis with 2.5 pM cycloheximide (Table II) . This treatment markedly reduced the proportion of MO taking up aged PMNs but did not affect uptake of EIgG. Furthermore, although cycloheximide treatment may be expected to inhibit synthesis of a wide range of proteins, "adding back" of TSP at 4 ,g/ml (but not Fn or albumin) to cycloheximide-inhibited MO partially "rescued" the capacity to ingest aged PMN (Table II) . Aging of freshly isolated PMNs for 22 h in the presence of 5 mM cycloheximide did not inhibit their subsequent recognition by Mo. Thus, treated PMNs were taken up by 55.9±4.2% of Mo, compared with 48.1±4.7% uptake of untreated PMNs by Mo (n = 4). These data indicated that macrophage-synthesized TSP plays a role in recognition of aged PMN. Exogenous TSP modulates macrophage recognition of apoptotic neutrophils. To examine whether TSP might be playing an adhesive role in the interaction, exogenous TSP was included in the interaction medium (Fig. 2) . At concentrations up to a peak of5 jg/ml, added TSP increased the proportion of M4 ingesting aged PMN. This effect was specific as albumin ( Fig. 2 ), Vn and Fn ( 12) at the same concentrations had no effect, and the potentiating effect ofadded TSP was completely inhibitable by mAb against TSP (Table III) . Furthermore, TSP did not induce Mo recognition of freshly isolated PMN. This indicated that although Mo have TSP associated with their surface, availability of "extra" TSP in solution appears to po- tentiate the interaction. Indeed, it appeared that the potentiating effect of 5 ug/ml TSP could be exerted at either cell surface, since preincubation of either cell type with TSP enhanced subsequent interaction under standard conditions (Fig. 3 ). By contrast, at higher concentrations, TSP specifically inhibited MO recognition of aged neutrophils; albumin had no effect at 100 ugg/ml, and TSP at this concentration did not affect My uptake of a control particle, the IgG-opsonized erythrocyte.
Although these results suggested that the role of TSP in the interaction might be to form a "molecular bridge" between Mq and aged PMN, further supportive evidence would come from demonstration that (a) TSP can support adhesion by both cell types; and (b) inhibition of TSP binding to either cell type inhibits the interaction.
TSP supports adhesion to apoptotic neutrophils. TSP can mediate adhesion of cells of monocyte/macrophage lineage (24, 27, 34). However, it has not been known whether TSP could support adhesion by apoptotic PMNs, which would be a In these experiments, 39 .0±3.4% (n = 9) of MO recognized aged PMNs under control conditions. The anti-TSP MAb was C6.7 at a 1:25 dilution ofascites; the control mAb was OX7 at the same dilution.
* P < 0.05; in separate experiments, this concentration of C6.7 was shown not to impair M,0 ingestion of EIgG.
prerequisite for a possible "bridging" role for TSP in the interaction. Apoptotic PMNs adhered to latex beads coated with TSP to a greater degree than beads coated with a Fn, used as an adhesive protein control (Table IV) . Furthermore, binding of apoptotic PMN to TSP-coated beads was specifically inhibited by three mAbs (C6.7, A6. 1, and A2.5) against TSP, but not by a fourth TSP mAb, D4.6. These data indicate that TSP can support adhesion to apoptotic PMNs. mAbs to TSP inhibit the interaction. Surface TSP was not detected on aged PMN (see above), indicating that if TSP were to "bridge" macrophage to apoptotic neutrophil, then either TSP in solution or TSP attached to the MO surface must bind to the apoptotic neutrophil. Therefore, in the absence of added TSP, mAbs to TSP shown to inhibit TSP binding to apoptotic PMNs might be expected to inhibit the interaction. Specific inhibition of M4 ingestion of aged PMN was observed for the three mAbs, C6.7, A6.1, and A2.5, while mAb D4.6 affected neither bead binding nor the interaction (Fig. 4 ). No mAb from this panel inhibited MO ingestion of EIgG. Furthermore, mAb 3E3, which recognizes the cell-binding domain of Fn and inhibits Fn adhesion to fibroblasts (52), failed to inhibit the interaction (data not shown), confirming that the inhibitory effect ofanti-TSP mAbs was not some general property of mAbs against adhesive proteins. Therefore, these experiments provided direct evidence in support of a "physiological" bridging role for TSP in the interaction. Inhibition ofmacrophage receptorsfor TSP specifically impairs recognition ofapoptotic neutrophils. A further strategy to examine whether TSP has a bridging role in the interaction would be to manipulate MO surface adhesion receptors for TSP. Attachment of macrophages to substrates coated with ligand so that receptors become modulated to the underside of the cell is a well-established method of down-regulating ligand Thrombospondin in Phagocytosis ofAged Neutrophils 1517 11, _ binding at the "free" surface of the cell (49, 53 There was no effect on ingestion of EIgG. In addition, treatment of the substrate with the control protein albumin had no effect. Therefore, this experiment appeared to confirm a role for TSP-binding structures on the MO in recognition of aged
PMNs. This result would be expected from the reported specificity of a0033 for TSP (27) . Nevertheless, it was also compatible with a role for other MO TSP receptors, although our previous observation that fucoidan failed to inhibit the interaction indicated that involvement of MO heparan sulfate proteoglycan was unlikely (26, 54) . However, we had not previously sought a role for another MO adhesion receptor with specificity for TSP, the 88-kD monomer, CD36 (25, 27) . An IgM mAb to CD36, SMO (40) inhibited MO recognition of aged neutrophils, but not of EIgG (Fig. 5 A) . A number of isotype control mAbs, including mAbs binding to either cell type, had no effect (data for one mAb shown in Fig. 5 A) , indicating that the inhibitory effect of SMO was highly unlikely to be caused by some nonspecific "steric" effect ofIgM binding to cell surfaces.
Furthermore, an IgG, mAb to CD36, ClMegl (40) , also specifically inhibited phagocytosis of aged neutrophils (to 41.4±5.3% of control, n = 6; no effect on EIgG uptake was seen). The inhibitory effect ofanti-CD36 mAbs was exerted at the MO surface; since preincubation of MO but not of neutrophils with CD36 mAbs inhibited recognition (Fig. 5 B) and CD36 mAbs did not bind to aged neutrophils as assessed by immunofluorescence flow cytometry (data not shown). In parallel experiments the SMO CD36 mAb bound specifically to MO (Fig. 1 ). Therefore, these data indicate a hitherto unexpected role for CD36 in the interaction.
Synergistic inhibition ofthe interaction by mAbs to the vitronectin receptor and CD36. Previously, we reported that mAbs to both subunits of macrophage a143 specifically inhibited MO recognition of aged neutrophils by > 70% (12) . However, in the current series of experiments a similar degree of inhibition was observed with the CD36 mAb SM4 (Fig. 5 ).
These observations are compatible with the possibility that MO CD36 and a^f,3 function together in recognition ofaged neutrophils. Thus, we studied the effects of a combination of anti-CD36 and anti-av,33 mAbs, each at a concentration causing only weak inhibition ofthe interaction when used individually.
The combination exerted a strong inhibitory effect on MO recognition of aged neutrophils which was synergistic rather than merely additive, in keeping with a cooperative role for the two receptors in recognition of the aged PMN (Fig. 6 ). This effect was specific because combination ofeither mAb with an irrelevant isotype control mAb did not result in synergistic inhibition and EIgG recognition was not affected.
Macrophage adherence to TSP is mediated by a "twopoint" mechanism. Taken together, the data above suggest that in promoting recognition ofaged neutrophils, TSP may bind to 39 .1±2.3% of M4 recognized aged neutrophils. The highest concentration of SM4 had no effect on the proportion of M) taking up EIgG (closed square). The control mAb was the isotype matched IgM CD15 mAb, 28 . The dotted lines are as defined in Fig. 2. In (B) , preincubation of M) but not neutrophil with a 1:25 dilution of SM4 (but not by control mAb 28) for 30 min at 4VC inhibited the interaction (open bars: mean±SE, n = 6) to a degree similar to that when the mAb was included only in the interaction medium. Under control conditions, 48 .9±5.2% of MO recognized aged neutrophils. both a,,03 and CD36 on the macrophage. Although inhibitor studies reported by others indicate that some cell types may use a single receptor mechanism to adhere to TSP (for example, an RGD-inhibitable integrin [27] ), there are examples of cells which use a "two-point" mechanism (55). Neither the tetra- peptide RGDS nor the aVl33 mAb 23C6 inhibited MO binding to TSP (Table V) , although both inhibit macrophage recognition of aged neutrophils. Similarly, mAb to CD36 failed to inhibit MO adhesion to TSP. However, the combination of CD36 mAb with either af3 mAb or RGDS (but not RGES) resulted in specific inhibition of MO to TSP. The failure of these inhibitors to block MO binding to Fn (56) was used as a control. These data therefore indicated that MO adhesion to TSP-coated surfaces involved cooperative binding by both CD36 and the RGD-inhibitable a433 vitronectin receptor integrin. Monoclonal antibodies were used as a 1:25 dilution of ascites, and tetrapeptides at 2.2 mM: When combined, the same final concentrations were achieved. In these experiments (n = 9), 686±51 My adhered per 10 wells to TSP-coated gelatin; 863±112 M0 adhered per
Discussion
In this study, we have examined the cell surface recognition mechanisms used by human MO in phagocytosis of intact aging human neutrophils that have undergone apoptosis, a potentially "injury limiting" mode of neutrophil removal operating at inflamed sites (8) . Our conclusions are that macrophagesynthesized TSP mediates the interaction by forming a molecular bridge between the the cell types. Furthermore, at the MO surface the data indicate that TSP binds to both CD36 and the a433 "vitronectin" receptor.
There is evidence that TSP mediates platelet-platelet, platelet-erythrocyte, and monocyte-platelet adhesion by acting as a "molecular bridge" between cells ( 17, 21, 24, 25) . These interactions may be potentiated by supplementing available TSP by addition of micromolar concentrations of exogenous TSP, and inhibited by higher concentrations which saturate TSP-binding sites. TSP-mediated agglutination of erythrocytes by activated platelets has also been reported to be inhibited by millimolar concentrations of aminosugars and basic aminoacids ( 16, 17) . This suggests that a bridging role for TSP should be sought in MO recognition of aged PMN, since we found that this interaction was also inhibited by similar concentrations of these cationic molecules ( 15) . The data obtained in this study support the possibility that MO-synthesized TSP has a bridging role in this phagocytic interaction. First, TSP is present, both in solution and associated with the MO surface. Second, the interaction is inhibited by reducing supply of TSP in the interaction (by treating MO with cycloheximide) and "rescued" by replenishing TSP supply. Third, the interaction is specifically potentiated by TSP, by an effect which preincubation studies show can be exerted at the surface of each cell type. Fourth, inhibition of TSP-mediated adhesion to aged PMN by mAbs to TSP inhibits the interaction. Fifth, high concentrations of soluble TSP specifically inhibit, and sixth, so does attachment of macrophages to surfaces coated with TSP, a maneuver known to down-regulate expression of adhesion receptors at the free surface of the cell. Finally, supplementation of existing TSP supply by including the protein in the interaction medium at concentrations around 5 ,ug/ml specifically potentiated recognition. It therefore appears reasonable to conclude that TSP plays a hitherto unexpected bridging role in MO recognition of aged neutrophils. This represents an important new addition to the functional repertoire of TSP, and the first defined molecular link between the surfaces of the apoptotic PMN and the MO.
Clearly, to understand the precise role played by TSP in the interaction, it will be necessary to define the receptors for TSP on both cell types. At present, the mechanisms by which TSP binds to aged neutrophils are unknown. Our current and previous data ( 12) indicate that CD36 and Avf3 play their roles at the surface of the Mo, since in both cases the inhibitory effects of mAbs were localized to the Mo, and neither receptor was detectable on the surface of aged PMNs by flow cytometry. Furthermore, our previous finding that fucoidan fails to inhibit the interaction ( 15) suggests that neither heparan-sulfate proteoglycan nor sulfatides are involved (23, 26, 54) . Since freshly isolated PMNs are not recognized by MI (8) , it appears likely that the mechanisms by which TSP binds to fresh PMN (31, 32) will prove to be different from those involved in TSP binding to aged PMN. Indeed, it is of interest that we found that the anti-TSP mAb A2.5 inhibited the adherence ofapoptotic PMN to TSP, while others found no effect upon the adherence of freshly isolated PMN to TSP (32) . Ongoing work on the alterations occurring in the PMN surface during apoptosis will examine possible changes in the nature of the adhesive interaction with TSP.
However, the current study advances understanding of the molecular interactions occurring at the MO surface during phagocytosis of apoptotic cells. First, the inhibitory effects of monoclonal antibodies to CD36 indicate a newly-identified role in recognition of aged PMNs for this 88-kD MO surface molecule, the physiological function of which has been obscure. The degree of inhibition observed (> 80%) is comparable to that reported earlier for mAbs to aC133 (12) . This suggests that the two receptors work in concert rather than mediating two independent phagocytic pathways, and this possibility was supported by synergistic inhibition ofthe interaction by combination of low concentrations of mAbs to CD36 and a,#3. Second, although there has been controversy as to whether either CD36 or a!f33 truly represent cellular adhesion receptors for TSP (57) (58) (59) , our studies of MO binding to TSP indicate that the two structures participate in a "two-point" adhesion mechanism for TSP. This combination of TSP receptors is different from those previously reported to mediate two-point adhesion to TSP by other cell types, but is consistent with the principle established by these workers (55) . Furthermore, interference with two-point MO adhesion to TSP provides an explanation for the individual and synergistic inhibitory effects of mAbs to CD36 and avf3 upon aged PMN ingestion. However, the data appear to raise an interesting paradox. Whereas inhibition of aged PMN ingestion occurs after blockade of either MO receptor for TSP, such blockade does not inhibit MO adhesion to TSP, which requires simultaneous blockade of both CD36 and aCf33. A possible explanation is that the conformation of substrate-bound TSP, as well as the substrate itself, may allow more avid binding of MO than the circumstances encountered in TSP-mediated "bridging" to the apoptotic PMN. The result would be that disruption of one receptor class is insufficient to promote MO displacement from a TSP-coated substrate, while it is adequate to prevent TSP-mediated phagocytosis of aged PMN. It can be further speculated that a specific conformation ofTSP presented by MO CD36 and af#3 is required for recognition and ingestion of apoptotic PMN. The candidate TSP epitopes binding to aCf33 and CD36 are thought to be located close to the carboxyl terminus of each subunit of the trimeric molecule ( 19, 20, 22) , offering possibilities of dual receptor interaction with a single TSP molecule. Further study will be needed to define the stochiometry and precise molecular mechanisms of interactions between aC#3,, CD36, and TSP occurring at the MO surface during recognition of apoptotic PMNs. It is important to consider how the proposed recognition mechanism might operate at the inflamed site in vivo. The potentiating effect of low concentrations of TSP suggests that supply ofthis protein may be at a premium in our standard "no added protein" interaction assay, but there is evidence that TSP is in plentiful supply soon after injury of a tissue (35) , presumably being secreted by platelets and a range of other cell types. Indeed, the transient presence of the molecule in the extracellular matrix of the healing skin wound corresponds with the time PMNs are being removed from this and other sites of self-limited inflammation (60) . Although the Avf3 integrin was originally thought to be specific for vitronectin ( 13, 61 ), this receptor has specificity for RGD-bearing proteins in addition to TSP, namely Fn and fibrinogen (27, (62) (63) (64) (65) . Fn has potential as a candidate for bridging aged PMN to MO, since it may mediate agglutination of trypsinized erythrocytes which can be inhibited by aminosugars and basic aminoacids, and because both macrophages and neutrophils may synthesize the protein (66) . However, by contrast with TSP, Fn did not enhance recognition of aged neutrophils by normal ( 12) or cycloheximide-inhibited MO, nor did a mAb to the cell-binding domain of fibronectin inhibit recognition. Similarly, neither Vn nor fibrinogen potentiated the interaction ( 12) . Therefore, the in vitro data mitigate against a bridging role for ligands ofthe avi3 other than TSP, and such a role also seems unlikely on the grounds that these molecules do not interact with CD36 (28, 57) . However, the data suggest the speculative possibility that in addition to local changes in pH, or in concentrations of charged molecules ( 15) , soluble or matrix-bound Fn or Vn, or proteolytic fragments of these molecules, may, in certain circumstances, inhibit aged PMN removal by interfering with TSP binding to M4 a,33, thus favouring release of PMN contents from dying cells and persistence of tissue injury. To conclude, human monocyte-derived macrophage recognition ofaging neutrophils undergoing apoptosis involves hitherto unknown functions for TSP and the macrophage surface molecule CD36. The data in this report indicate that TSP acts as a molecular bridge between apoptotic neutrophil and macrophage. At the macrophage surface, the evidence suggests that TSP forms an adhesive complex involving macrophage CD36 and the af33 integrin. Further study of the mechanisms by which TSP binds to apoptotic neutrophils will provide a new approach to the identification of the surface changes that occur in apoptotic cells to lead to their recognition as "senescentself." This study also implies that proteins that are frequently incorporated into the extracellular matrix at inflamed sites may play an important role in regulation ofmacrophage recognition of apoptotic neutrophils, a cellular interaction that has potential to limit the toxic potential ofneutrophils in inflammation.
